Action of MK-7264 (gefapixant) at human P2X3 and P2X2/3 receptors and in vivo efficacy in models of sensitisation

Capabilities

---

Knowledge Center

---

Laboratory Chemistry

Connect with a Scientific Expert

Authors: David Richards, Joel R. Gever, Anthony P. Ford, Samuel J. Fountain

Br J Pharmacol. 2019 Jul;176(13):2279-2291

DOI: 10.1111/bph.14677

Access the publication at:https://pubmed.ncbi.nlm.nih.gov/30927255/